Preventing Acquired Resistance: Strengthen TB Treatment by Adding Amikacin in the First Treatment Week of Multidrug-resistant Tuberculosis

NCT05555303 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis, Multidrug-Resistant

Interventions

DRUG: Amikacin

Sponsor

Rwanda Biomedical Centre

Collaborators

[object Object]
[object Object]